Welcome new supporter – AltheaMay 2, 2023 | IN NEWS | BY MCCS
We are delighted to extend a warm welcome to our newest supporter, Althea. Their commitment to our cause further strengthens our mission and reinforces the importance of collaboration within the medical cannabis sector.
Althea, a global pharmaceutical company, specialises in distributing medicinal cannabis products to various markets such as the United Kingdom, Ireland, Germany, Australia, and South Africa. They use their extensive expertise to collaborate with healthcare professionals, educating them on the clinical usage of medicinal cannabis and simplifying prescribing pathways to achieve the best clinical outcomes for patients.
Proudly offering Concierge, a Therapeutic Goods Administration-registered medical device, Althea delivers a range of education, access, and management tools to assist healthcare professionals and eligible patients in navigating medicinal cannabis treatment pathways. To learn more, one can register for Concierge here: Login – Althea Concierge, or contact [email protected].
We are proud to offer Concierge, a Therapeutic Goods Administration-registered medical device, which provides a range of education, access, and management tools to support healthcare professionals and eligible patients in navigating medicinal cannabis treatment pathways. To learn more, register for Concierge at the following link Login – Althea Concierge or contact [email protected].
Focusing on quality and consistency, Althea’s comprehensive portfolio of full-spectrum products is manufactured in accordance with Good Manufacturing Practice regulations. The company believes in the potential value of the entourage effect offered by full-spectrum products (*1&2).
For more information about Althea, their product portfolio, and the services they provide, please reach out to them at [email protected].
Supporting the MCCS
The Medical Cannabis Clinicians Society is grateful for the continued support from licensed producers, industry leaders, and individuals alike, which enables us to achieve our objectives.
This generous unrestricted educational grant funding empowers the Society to offer CPD-accredited training, events, and peer support, fostering the development and expansion of the UK’s largest and most esteemed network of prescribers.
Organizations interested in collaborating with the Society are encouraged to reach out and discover the advantages of joining forces to enhance our collective impact.
1. Russo, E., 2019. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain. Frontiers in Plant Science, 9.
2. Baron, E., 2018. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache, 58(7), pp.1139-1186.